BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32596394)

  • 1. Identification of an Individualized Prognostic Signature Based on the RWSR Model in Early-Stage Bladder Carcinoma.
    Liu L; Zhong X; Cui H; Zhang H; Wang L; Liu Y
    Biomed Res Int; 2020; 2020():9186546. PubMed ID: 32596394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a tumor microenvironment-related seven-gene signature for predicting prognosis in bladder cancer.
    Wang Z; Tu L; Chen M; Tong S
    BMC Cancer; 2021 Jun; 21(1):692. PubMed ID: 34112144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A co-expression network for differentially expressed genes in bladder cancer and a risk score model for predicting survival.
    Chen Z; Liu G; Hossain A; Danilova IG; Bolkov MA; Liu G; Tuzankina IA; Tan W
    Hereditas; 2019; 156():24. PubMed ID: 31333338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
    Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
    Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma.
    Bao Z; Zhang W; Dong D
    Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes.
    Wang L; Wang Y; Wang J; Li L; Bi J
    J Immunol Res; 2021; 2021():3236384. PubMed ID: 34708131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The construction and validation of an RNA binding protein-related prognostic model for bladder cancer.
    Chen F; Wang Q; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):244. PubMed ID: 33685397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.
    He RQ; Zhou XG; Yi QY; Deng CW; Gao JM; Chen G; Wang QY
    Cell Physiol Biochem; 2018; 48(3):1355-1368. PubMed ID: 30048970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer.
    Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H
    BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An RNA-sequencing-based transcriptome for a significantly prognostic novel driver signature identification in bladder urothelial carcinoma.
    Liu D; Zhou B; Liu R
    PeerJ; 2020; 8():e9422. PubMed ID: 32742772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma.
    Lin P; Wen DY; Chen L; Li X; Li SH; Yan HB; He RQ; Chen G; He Y; Yang H
    Eur Radiol; 2020 Jan; 30(1):547-557. PubMed ID: 31396730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An eight-long non-coding RNA signature as a candidate prognostic biomarker for bladder cancer.
    Lian P; Wang Q; Zhao Y; Chen C; Sun X; Li H; Deng J; Zhang H; Ji Z; Zhang X; Huang Q
    Aging (Albany NY); 2019 Sep; 11(17):6930-6940. PubMed ID: 31479417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Prognosis and Recurrence of Bladder Cancer by ECM-Related Genes.
    Zhao H; Chen Z; Fang Y; Su M; Xu Y; Wang Z; Gyamfi MA; Zhao J
    J Immunol Res; 2022; 2022():1793005. PubMed ID: 35450397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Three Protein-Coding Gene Prognostic Model Predicts Overall Survival in Bladder Cancer Patients.
    Ning XH; Qi YY; Wang FX; Li SC; Jia ZK; Yang JJ
    Biomed Res Int; 2020; 2020():7272960. PubMed ID: 33150179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer.
    Liu CP; Zhang JH; Zheng SC; Liu J; Guo JC
    Oncol Rep; 2018 Nov; 40(5):2826-2835. PubMed ID: 30226624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of members of NFAT family for pan-cancer and a prediction model based on NFAT2 in bladder cancer.
    Dai ZT; Xiang Y; Wang Y; Bao LY; Wang J; Li JP; Zhang HM; Lu Z; Ponnambalam S; Liao XH
    Aging (Albany NY); 2021 May; 13(10):13876-13897. PubMed ID: 33962392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a prognostic index and screening of prognosis related genes based on an immunogenomic landscape analysis of bladder cancer.
    Qu G; Liu Z; Yang G; Xu Y; Xiang M; Tang C
    Aging (Albany NY); 2021 Apr; 13(8):12099-12112. PubMed ID: 33888644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a basement membrane-related genes signature with immune correlation in bladder urothelial carcinoma and verification in vitro.
    Li Y; Xu K; Zhang Y; Mao H; Qiu Q; Yan Z; Liu X; Du Y; Chen Z
    BMC Cancer; 2023 Oct; 23(1):1021. PubMed ID: 37872487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.